Featured Article
A recent study in Nature suggests that the epigenome plays a critical role in driving the long-lasting obesogenic metabolic memory, making it hard to keep weight off after obesity treatment.
Precision Oncology Today
Magazine
5 Key Startups Bringing Digital Pathology Into Focus
Digital pathology is driving precision medicine by turbocharging the analysis of tissue slides. Here are the five top startups turning microscopy into a data...
How Is Artificial Intelligence Changing the Clinical Trials Landscape?
There is no doubt that artificial intelligence (AI) is currently en vogue. Many AI and machine-learning applications are already being deployed in drug discovery and development. Not only can AI process, analyze, and interpret huge datasets, it can also be used for structural drug design and toxicity and efficacy predictions.
Trending on Inside Precision Medicine
Cure51 Launches Major Study of Cancer “Super-Responders”
Cure51 and several collaborators are “seeking to unlock the biological mechanisms responsible for exceptional cancer survivors.”
Novel AI Tool “Sees” Gene Expression in Tumor Biopsy Images
A tool created using artificial intelligence can detect gene expression levels within tumor cells using just standard microscopy images of the tumor biopsy, and can predict a patient's risk for breast cancer recurrence.
Cancer-Like Genetic Mutations Found in Healthy Breast Tissue Cells
The findings suggest that cancer-like mutations appear silently in breast cells that appear normal, potentially offering insights into the origins of the disease.